Stem cells may lead the way towards innovative treatments for eye disease. Hear from experts on the latest research.

Moderated by Dennis Clegg, PhD, UC Santa Barbara

Kristin MacDonald: Patient Perspective

Henry Klassen, MD, PhD, UCI: Retinal Progenitor Cells for Treatment of Retinitis Pigmentosa

Theodore Leng, MD, MS, Stanford University: NeuBright, a purified allogeneic cell therapy product for treatment of Dry Age-related Macular Degeneration

Sophie Deng, MD, PhD, UCLA: Limbal stem cell therapy Series: "Stem Cell Channel" [Health and Medicine] [Science] [Show ID: 36327]